Xealth is a digital health startup founded in 2017 and based in the United States, which operates under the slogan "Digital health tools, ordered and delivered from the EHR workflow. Digital health at scale." The company's primary focus is on enabling healthcare teams to order digital content and services as easily as they do orders and medications, allowing patients to access these digital health prescriptions from the provider's portal to actively manage their health. Notably, Xealth has received recognition in the industry, being listed in the CB Insights Digital Health 150, named in Fierce Healthcare's Fierce 15 2023, and recognized in AVIA Marketplace's Top Digital Therapeutics. In their most recent funding round on 27 February 2024, Xealth secured a $3.44M Venture Round investment, showcasing the continued interest and support from potential investors in the company's vision and potential for growth.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $3.44M | - | 27 Feb 2024 | |
Series B | $25.00M | 10 | UPMC, Novant Health +4 | 05 Oct 2021 |
Venture Round | $6.00M | 2 | Cerner Capital | 06 Aug 2020 |
Series A | $3.00M | 4 | Atrium Companies | 20 Jun 2019 |
Series A | $11.00M | 7 | UPMC, Philips Healthcare +2 | 27 Mar 2019 |
No recent news or press coverage available for Xealth.